Page 13 - Nccn Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nccn guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nccn Guidelines Today - Breaking & Trending Today

Evolving Field of Molecular Testing in Non–Small Cell Lung Cancer

Expert oncologists reflect on the current state of molecular testing in patients with non–small cell lung cancer and how it has impacted treatment pathways. ....

Treating Uncommon , Molecular Testing , Small Cell Lung Cancer , Non Small Cell Lung Cancer , Lung Cancer , Metastatic Lung Cancer , Metastatic Nsclc , Biomarker Testing , Tissue Testing , Tissue Biopsy , Liquid Biopsy , Ctdna Testing , Circulating Tumor Dna , Rna Testing , Rna Test , Immune Checkpoint Inhibitors , Targeted Therapy , Egfr Mutation , Walk Testing , Kras G12c , Met Alteration , Nccn Guidelines , Ngs Testing , Next Generation Sequencing ,

Advanced Ovarian Cancer: Current Treatment Landscape in Second- and Later-Line Settings

Expert oncologists review the current PARP inhibitor treatment indications for patients with advanced ovarian cancer and discuss how to best manage patients who have been impacted by the recent updates to the PARP inhibitors. ....

Advanced Ovarian Cancer Treatment , Recent Updates , Later Line Maintenance Settings , Ovarian Cancer , Current Treatment Landscape , Advanced Ovarian Cancer , Recurrent Advanced Ovarian Cancer , Study 19 , Nova Trial , Ariel 3 , Nccn Guidelines , Platinum Chemotherapy ,

Besremi Designated as Preferred Treatment for Polycythemia Vera

Two years after receiving FDA approval, Besremi is a preferred treatment option in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. ....

New York , United States , John Mascarenhas , Raymond Urbanski , Icahn School Of Medicine At Mount Sinai , Drug Administration , Pharmaessentia United , Icahn School , Mount Sinai , Polycythemia Vera , Nccn Guidelines ,

Dr Malalur on Addressing Unmet Needs in Pancreatic Cancer

Pannaga G. Malalur, MBBS, discusses several unmet needs within pancreatic cancer, including the implementation of updated germline genetic testing guidelines, increased screening of high-risk patients, and improved sequencing of available therapeutics. ....

Pannagag Malalur , National Comprehensive Cancer Network , James Cancer Hospital Solove Research Institute , Ohio State University Comprehensive Cancer Center , Gastrointestinal Cancers , Cancer Hospital , Solove Research Institute , Cancers Symposium , Osuccc James , The Ohio State University Comprehensive Cancer Center James Hospital Amp Solove Research Institute , Gastrointestinal Cancer , Onclive Tv , Pancreatic Ductal Adenocarcinoma , Germline Genetic Testing , Nccn Guidelines , Screening Tools , Next Generation Sequencing ,

Safety and Efficacy Data on Radium-223 for the Palliative Treatment of mCRPC

Drs Armstrong and Manning review the safety and efficacy data from the ALSYMPCA trial of radium-223 in patients with mCRPC. ....

Treatment Approach , Metastatic Castration Resistant Prostate Cancer , Efficacy Data , Palliative Treatment , Prostate Cancer , Mcrpc Treatment , Mcrpc Radiation , Mcrpc Medical Oncology , Bone Pain , Palliative Radiation , Sabr Comet , Nccn Guidelines , Radium 223 ,